|
2024
|
Invention
|
Modified tnf as a capture ligand.
A column is disclosed for removal of sTNF-R2 from a body fluid... |
|
2023
|
Invention
|
Increasing responses to checkpoint inhibitors by extracorporeal apheresis.
The invention provide... |
|
|
Invention
|
Il-6 removal. The present invention relates to a column for removing IL-6 from a blood component ... |
|
2022
|
Invention
|
Reduced leaching of a ligand.
A column for removal of a component from a fluid is disclosed. The... |
|
|
Invention
|
Modified tnf as a capture ligand. A column is disclosed for removal of sTNF-R2 from a body fluid.... |
|
|
Invention
|
System and method for removal of immune inhibitors from biological fluids.
The present system an... |
|
|
Invention
|
Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of i... |
|
2021
|
Invention
|
Increasing responses to checkpoint inhibitors by extracorporeal apheresis. The invention provides... |
|
2020
|
Invention
|
Reduced leaching of a ligand. A column for removal of a component from a fluid is disclosed. The ... |
|
2019
|
Invention
|
System and method for removal of immune inhibitors from biological fluids. The present system and... |
|
|
Invention
|
System and method for removal of immune inhibitors from biological fluids. The present syst... |
|
2018
|
G/S
|
medical devices for performing immunotherapy and blood filtering for medical purposes including t... |
|
|
G/S
|
medical devices for performing immunotherapy for medical purposes including treatment of cancer, ... |
|
2017
|
Invention
|
Method to treat cancer using therapeutic apheresis to remove tgf-β via its complexes. Embodiments... |
|
|
Invention
|
Nanoparticle compositions comprising adenosine receptor antagonists and methods of use. A nanopar... |
